Vicapsys Life Sciences, Inc. (VICP)

OTCMKTS: VICP · Delayed Price · USD

9.00

+3.35 (59.29%)

Jun 28, 2024, 1:25 PM EDT - Market closed

Vicapsys Life Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2009	2008
Net Income	-1.67	-0.14	-0.77	-1.41	-1.67	Upgrade
Depreciation & Amortization	0.03	0.03	0.03	0.03	0.12	Upgrade
Share-Based Compensation	0.11	0	0.01	0.12	0.24	Upgrade
Other Operating Activities	1.29	-0.34	0.46	0.29	-0.08	Upgrade
Operating Cash Flow	-0.24	-0.44	-0.26	-0.97	-1.39	Upgrade
Capital Expenditures	0	0	0	0	-0.08	Upgrade
Acquisitions	0	0.1	0	0	0	Upgrade
Change in Investments	-	-0.1	-	-	-	Upgrade
Other Investing Activities	-	0.1	-	-	0.01	Upgrade
Investing Cash Flow	0	0.1	0	0	-0.07	Upgrade
Common Stock Issued	0.03	0.56	0	0.97	0	Upgrade
Other Financing Activities	-	-	-	0.18	1.52	Upgrade
Financing Cash Flow	0.03	0.56	0	1.15	1.52	Upgrade
Net Cash Flow	-0.2	0.22	-0.26	0.18	0.06	Upgrade
Free Cash Flow	-0.24	-0.44	-0.26	-0.97	-1.47	Upgrade
Free Cash Flow Margin	-	-	-	-	-18.88%	Upgrade
Free Cash Flow Per Share	-0.01	-0.03	-0.02	-0.09	-4.24	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.